WO2006111256A1 - Body cleaning composition in a novel application form for cosmetics - Google Patents

Abstract

The invention relates to a bath foam concentrate with a total water content of max. 7 wt. % and a content of surfactants, polyols and at least one fatty component contained in a water-soluble liquid film.

Description

"Body cleansing composition in cosmetics for new application form"

The invention relates to Schaumbadkonzentrate with a water content of at most 7 wt .-%, which are included in a water-soluble liquid film.

Bubble baths are added to the bath water and have the task to develop a voluminous, fine bubble foam, to give the bath water a pleasant scent and to cleanse the body. Especially with longer bath time, the skin can be degreased and damaged by the water and the degreasing effect of the surfactants in the foam baths. In the past, it has therefore been proposed to counteract this problem by adding cosmetic oil components, moisturizing and skin moisturizing active ingredients and / or water-soluble proteins or protein degradation products while at the same time improving the skin condition.

DE-OS 29 43 202 describes Pflegeschaumbademittel with 20 to 80 wt .-% surface-active substances and 20 to 80 wt .-% cosmetic oils. Also DE-OS 27 00 891 describes bath additives. These contain 40 to 75% by weight of surface-active substances and 15 to 50% by weight of cosmetic oils. The high surfactant content in the formulations serves to largely solubilize the cosmetic oils or to render them dispersible in water. However, the products are not satisfactory in terms of foaming power and leave unwanted, noticeably oily residues on the skin. Other highly concentrated surfactant compositions have the disadvantage of being stiff pastes or of forming difficultly dissolvable solid gel particles when attempting to dissolve the products in water, which in turn is remedied by the addition of solvents or solubilizers.

For this reason, EP 288 919 A1 has proposed a foam bath concentrate which develops a rich foam, solubilizes high quantities of perfume oil, neither exerts a damaging effect on the skin nor leaves an oily film on the skin, and dissolves quickly and easily in water. The bubble bath comprises from 35 to 45% by weight of anionic surfactants, from 5 to 15% by weight of nonionic surfactants, from 1 to 5% by weight of zwitterionic surfactants, and from about 3 to 15% by weight of cosmetic oil components.

The total surfactant content of the Schaumbadkonzentrate is still at least 41 wt .-%, otherwise the high oil quantities can not be satisfactorily solubilized. Another problem is that the foam volume is still perceived by the consumer due to the high oil content in the bubble bath as insufficient and the foam bath is therefore often added to the bath water to achieve a larger foam volume in too large a dosage. As a result, the above-mentioned problems on the skin occur again.

The aim of the present invention was thus to provide a Schaumbadkonzentrat, which does not have the disadvantages mentioned above.

This object has been achieved to a great extent by the low water content foam bath concentrate of the invention contained in a water-soluble liquid film.

The invention therefore provides a Schaumbadkonzentrat with a total water content of at most 7 wt .-%, containing surfactants, polyols and at least one fatty substance component and is included in a water-soluble liquid film.

The Schaumbadkonzentrate invention are characterized by good foaming and skin compatibility. Packaging the concentrate in a water-soluble wrapper ensures that only the amount of concentrate required for a full bath is released by quick, easy and residue-free dissolution of the wrapper. This is advantageous for the condition of the skin as well as for cost reasons. The water-soluble packaging is not destroyed, due to the low water content of not more than 7% by weight.

According to the invention suitable liquid films are made of polyvinyl alcohol and have a thickness of 70 to 80 microns and a dimension of 130 to 150 x 80 to 90 mm. Particularly suitable are the liquid films sold under the trade name M 8630 by the company Monosol (Chris Graft). As a suitable disposable portion of the Schaumbadkonzentrats invention, they have a thickness of about 76 microns and a dimension of about 145 x 85 mm.

In a preferred embodiment of the invention, the Schaumbadkonzentrate contain a mixture of anionic and nonionic surfactants.

Anionic surfactants which are particularly suitable according to the invention are the alkyl ether sulfate surfactants corresponding to the formula RO (CH ₂ -CH ₂ O) _x -OSO ₃ X in which R is a preferably linear alkyl group having 8 to 30 C atoms, x = O or 1 to 12 and X is an alkali metal, alkaline earth metal or ammonium cation , According to the invention, sodium or ammonium lauryl ether sulfates having a degree of ethoxylation of 2 to 4 are particularly suitable. They are present in the foam bath concentrates according to the invention - preferably in an amount of 12 to 25% by weight and in particular in an amount of 15 to 20% by weight. -% used.

Suitable nonionic surfactants according to the invention are compounds of the formula

RA- (C ₂ H ₄ O) _x -H, where R is an alkyl, alkenyl or acyl group of 10 to 18 carbon atoms, A is an oxygen atom or an -NH group and x is a number from 2 to 10 stands.

Particularly suitable are laureth-2 and / or laureth-4. They are used in the foam bath concentrates according to the invention - based on their total weight - preferably in an amount of 8 to 15 wt .-% and in particular in an amount of 10 to 14 wt .-%.

Furthermore, alkyl polyglucosides can be used as nonionic surfactants suitable according to the invention.

Inventive Alkylpolygykoside according to the general formula RO- (Z) _x

where R is alkyl, Z is sugar and x is the number of sugar units. The alkyl polyglycosides which can be used according to the invention can only contain one particular alkyl radical R. Usually, however, these compounds are prepared starting from natural fats and oils or mineral oils. In this case, the alkyl radicals R are mixtures corresponding to the starting compounds or corresponding to the particular work-up of these compounds.

And C _O alkyl groups, consisting essentially of C ₁₂ - - and C ₁₄ alkyl groups, essentially of C ₈ - to C ₁₆ -alkyl groups or consists essentially of C ₁₂ alkyl polyglycosides are those in which R consists essentially of C ₃ are particularly preferred - To Ci ₆ alkyl groups or consists essentially of C ₁₆ to C ₁₈ alkyl groups. - A -

As sugar unit Z it is possible to use any mono- or oligosaccharides. Usually, sugars with 5 or 6 carbon atoms and the corresponding oligosaccharides are used. Such sugars are, for example, glucose, fructose, galactose, arabinose, ribose, xylose, lyxose, allose, altrose, mannose, gulose, idose, talose and sucrose. Preferred sugar building blocks are glucose, fructose, galactose, arabinose and sucrose; Glucose is particularly preferred.

The alkyl polyglycosides which can be used according to the invention contain on average from 1.1 to 5 sugar units. Alkyl polyglycosides having x values of 1.1 to 2.0 are preferred. Very particular preference is given to alkyl glycosides in which x is 1.1 to 1.8.

The alkoxylated homologs of said alkyl polyglycosides can also be used according to the invention. These homologs may contain on average up to 10 ethylene oxide and / or propylene oxide units per alkyl glycoside unit.

Alkylpolyglucosides particularly preferred are the commercial products Plantacare® ^® 1200 UP, Plantacare® ^® 818 UP and Plantacare® ^® 2000 UP from Cognis. They are used in the foam bath concentrates according to the invention - based on their total weight - preferably in an amount of 8 to 15 wt .-% and in particular in an amount of 10 to 14 wt .-%.

Polyols suitable according to the invention preferably contain 2 to 15 carbon atoms and at least two hydroxyl groups. Typical examples are

• glycerin;

Alkylene glycols, such as, for example, ethylene glycol, diethylene glycol, propylene glycol, butylene glycol, hexylene glycol and polyethylene glycols having an average molecular weight of from 100 to 1000 daltons, in particular having a molecular weight of from 400 to 600 daltons;

Technical Oligoglyceringemische with an intrinsic degree of condensation of 1, 5 to 10 such as technical Diglyceringemische with a diglycerol content of 40 to 50 wt .-%;

Methyolverbindungen, in particular trimethylolethane, trimethylolpropane, trimethylolbutane, pentaerythritol and dipentaerythritol;

Lower alkyl glucosides, in particular those having 1 to 8 carbons in the alkyl radical, such as, for example, methyl and butyl glucoside; Sugar alcohols having 5 to 12 carbon atoms, such as sorbitol or mannitol,

• sugars having 5 to 12 carbon atoms, such as glucose or sucrose;

• Amino sugars, such as glucamine.

The Schaumbadkonzentrate particularly preferably contain mixtures of several polyols. Particularly preferred is a mixture of at least two representatives of the group glycerol, sorbitol, 1,2-propylene glycol and / or polyethylene glycol.

The polyol mixture is used in the Schaumbadkonzentraten particularly preferably in amounts of 30 to 65 wt .-% and in particular in amounts of 40 to 60 wt .-%.

Glycerol polyglycol ether monofatty acid esters which are suitable according to the invention are hydrophilic oil components with skin-moisturizing action. Products of this structure are known from the literature, for example from DE-A-20 24 051. and commercially, for example under the trademark Cetiol ^® HE (Cognis). According to the invention suitable fatty acid mono- or diglyceride polyglycol ether are also lietraurbekannt as refatting Komponeten, for example from US 2,617,754 and from DE A-14 67 816. Particularly suitable Cetiol ^® HE. This commercial product is used in the Schaumbadkonzentraten - based on the total weight, preferably in amounts of 2 to 6 wt .-%.

In a particularly preferred embodiment of the invention, the Schaumbadkonzentrate further contain a cationic polymer.

Cationic polymers are polymers which have groups in the main and / or side chain which may be "temporary" or "permanent" cationic. According to the invention, "permanently cationic" refers to those polymers which have a cationic group independently of the pH of the agent These are generally polymers which contain a quaternary nitrogen atom, for example in the form of an ammonium group Preferred cationic groups are quaternary ammonium groups In particular, those polymers in which the quaternary ammonium group is bonded to a polymer main chain composed of acrylic acid, methacrylic acid or derivatives thereof via a C 1-4 hydrocarbon group have been found to be particularly suitable.

Homopolymers of the general formula (IV),

where R ^{17 is} -H or -CH ₃ , R ¹⁸ , R ¹⁹ and R ^{20 are} independently selected from C _1-4 alkyl, alkenyl or hydroxyalkyl groups, m = 1, 2, 3 or 4 , n is a natural number and X ^"is a physiologically acceptable organic or inorganic anion, as well as copolymers consisting essentially of the monomer units listed in formula (III) and nonionic monomer units are particularly preferred cationic polymers Within the scope of these polymers, those are preferred according to the invention for which at least one of the following conditions applies:

- R ¹⁷ is a methyl group

- R ¹⁸ , R ¹⁹ and R ²⁰ are methyl groups

- m has the value 2.

Suitable physiologically tolerated counterions X ^" are, for example, halide ions, sulfate ions, phosphate ions, methosulfate ions and organic ions such as lactate, citrate, tartrate and acetate ions, preference being given to halide ions, in particular chloride.

A suitable homopolymer is the, if desired cross-linked, poly (methacryloyloxyethyltrimethylammonium chloride) with the INCI name Polyquaternium-37. The crosslinking can, if desired, be carried out with the aid of poly olefinically unsaturated compounds, for example divinylbenzene, tetraallyloxyethane, methylenebisacrylamide, diallyl ether, polyallylpolyglyceryl ethers, or allyl ethers of sugars or sugar derivatives such as erythritol, pentaerythritol, arabitol, mannitol, sorbitol, sucrose or glucose. Methylenebisacrylamide is a preferred crosslinking agent.

The homopolymer is preferably used in the form of a nonaqueous polymer dispersion which should not have a polymer content of less than 30% by weight. Such polymer dispersions are available under the names Salcare ^® SC 95 (about 50% polymer content, additional components: mineral oil (INCI name: Mineral Oil) and tridecyl polyoxypropylene pylene-polyoxyethylene-ether (INCI name: PPG-1-Trideceth- 6)), and Salcare ^® SC 96 (about 50% polymer content, additional components: mixture of diesters of propylene Glykols with a mixture of caprylic and capric acid (INCI name: Propylene Glycol Dicaprylate / Dicaprate) and tridecyl-polyoxypropylene-polyoxyethylene ether (INCI name: PPG-1-Trideceth-6)) commercially available.

Copolymers having monomer units of the formula (VI) contain as nonionic monomer units preferably acrylamide, methacrylamide, acrylic acid-C _1-4 -alkyl esters and methacrylic acid-C _1-4 -alkyl esters. Among these nonionic monomers, the acrylamide is particularly preferred. These copolymers can also be crosslinked, as described above in the case of the homopolymers. A copolymer preferred according to the invention is the crosslinked acrylamide-methacryloyloxyethyltrimethylammonium chloride copolymer. Such copolymers in which the monomers are present in a weight ratio of about 20:80, commercially available as about 50% non-aqueous polymer dispersion under the name Salcare ^® SC 92nd

Other preferred cationic polymers are, for example, quaternized cellulose derivatives, such as are available under the names of Celquat ^® and Polymer JR ^® commercially. The compounds Celquat ^® H 100, Celquat L 200 and Polymer JR ^{® ®} 400 are preferred quaternized cellulose derivatives

- cationic alkyl polyglycosides according to DE-PS 44 13 686, cationized honey, for example the commercial product Honeyquat ^® 50, cationic guar derivatives, in particular the products sold under the trade names cos media ^® guar and Jaguar ^®,

Quaternary group polysiloxanes, such as the commercially available products Q2-7224 (manufactured by Dow Corning, a stabilized trimethylsilylamodimethicone), Dow ^Corning® 929 emulsion (containing a hydroxylamino-modified silicone, also referred to as amodimethicones) , SM-2059 (manufacturer: General Electric), SLM-55067 (manufacturer: Wacker) and Abil ^® Quat 3270 and 3272 (manufacturer: Th. Goldschmidt, diquaternary polydimethylsiloxanes, quaternium-80), polymeric dimethyldiallylammonium salts and their copolymers with esters and Amides of acrylic acid and methacrylic acid. Under the names Merquat ^® 100 (Poly (dimethyldiallylammoniurnchlorid)) and Merquat ^® 550 (dimethyldiallylammonium chloride-acrylamide copolymer) commercially available products are examples of such cationic polymers, - Copolymers of vinylpyrrolidone with quaternized derivatives of dialkylaminoalkyl acrylate and methacrylate, such as diethyl sulfate quaternized vinylpyrrolidone-dimethylaminoethyl methacrylate copolymers. Such compounds are sold under the names Gafquat ^® 734 and Gafquat ^® 755 commercially,

- vinylpyrrolidone vinylimidazoliummethochloride copolymers, such as those offered under the names Luviquat.RTM ^® FC 370, FC 550, FC 905 and HM 552,

- Quaternized polyvinyl alcohol, as well as those under the names

Polyquaternium 2,

- Polyquaternium 17,

- Polyquaternium 18 and

Polyquaternium 27 known polymers with quaternary nitrogen atoms in the polymer main chain.

Can be used as cationic polymers (. B. commercial product, Quatrisoft ^® LM 200) under the designations Polyquaternium-24, known polymers. Also usable in the invention are the copolymers of vinylpyrrolidone, such as the commercial products Copolymer 845 (manufactured by ISP), Gaffix ^® VC 713 (manufactured by ISP), Gafquat ^® ASCP 1011, Gafquat ^® HS 110, Luviquat ^® 8155 and Luviquat ^® MS 370 available are.

Other cationic polymers of the invention are the "temporarily cationic" polymers. These polymers usually contain an amino group present at certain pH values as a quaternary ammonium group and thus cationic are preferred, for example, chitosan and its derivatives, such as, for example, under the trade designations Hydagen ^®. , Hydagen® ^® HCMF, Kytamer ^® PC and Chitolam ^® NB / 101 are freely available commercially CMF. chitosans are deacetylated, in different degrees of deacetylation and varying degrees of degradation (molecular weights) are commercially available. Their preparation is, for example, in DE 44 40 625 A1 and described in DE 1 95 03 465 A1.

Especially suitable chitosans have a degree of deacetylation of at least 80% and a molecular weight of 5 ^× 10 ⁵ to 5 ^× 10 ⁶ (g / mol). For the production of preparations according to the invention, the chitosan must be converted into the salt form. This can be done by dissolving in dilute aqueous acids. Suitable acids are both mineral acids such as hydrochloric acid, sulfuric acid and phosphoric acid and organic acids, for example low molecular weight carboxylic acids, polycarboxylic acids and hydroxycarboxylic acids. Furthermore, higher molecular weight alkyl sulfonic acids or alkyl sulfuric acids or organophosphoric acids can be used, provided that they have the required physiological compatibility. Suitable acids for converting the chitosan into the salt form are, for example, acetic acid, glycolic acid, tartaric acid, malic acid, citric acid, lactic acid, 2-pyrrolidinone-5-carboxylic acid, benzoic acid or salicylic acid. Preference is given to using low molecular weight hydroxycarboxylic acids, for example glycolic acid or lactic acid.

Particularly preferred cationic polymers are Polyquaternium-7 (Merquat 550), Polyquaternium-6, Polyquaternium-10, as well as all of the cationic guar derivatives ^®.

They are used in the compositions according to the invention preferably in amounts of from 0.1 to 5% by weight, based on the total agent. Amounts of from 0.2 to 3, especially from 0.5 to 2 wt .-%, are particularly preferred.

According to a further preferred embodiment of the invention, the Schaumbadkonzentrate contain a further surfactant. These may be selected from anionic, zwitterionic or amphoteric, nonionic or cationic surfactants.

Suitable anionic surfactants in preparations according to the invention are all anionic surfactants suitable for use on the human body. These are characterized by a water-solubilizing, anionic group such as. As a carboxylate, sulfate, sulfonate or phosphate group and a lipophilic alkyl group having about 8 to 30 carbon atoms. In addition, glycol or polyglycol ether groups, ester, ether and amide groups and hydroxyl groups may be present in the molecule. Examples of suitable anionic surfactants are, in each case in the form of the sodium, potassium and ammonium as well as the mono-, di- and trialkanolammonium salts having 2 to 4 C atoms in the alkanol group,

linear and branched fatty acids with 8 to 30 carbon atoms (soaps), - Ethercarbonsäuren the formula RO- (CH2-CH2θ) _x -CH2-COOH, in which R is a linear

Alkyl group having 8 to 30 C atoms and x = 0 or 1 to 16,

Acylsarcosides having 8 to 24 C atoms in the acyl group,

Acyltaurides having 8 to 24 carbon atoms in the acyl group,

Acyl isethionates having 8 to 24 C atoms in the acyl group,

Sulfosuccinic acid mono- and dialkyl esters having 8 to 24 C atoms in the alkyl group and sulfosuccinic acid monoalkyl polyoxyethyl esters having 8 to 24 C atoms in the alkyl group and 1 to 6 oxyethyl groups,

- linear alkanesulfonates having 8 to 24 carbon atoms,

- linear alpha-olefin sulfonates having 8 to 24 carbon atoms,

Alpha-sulfofatty acid methyl esters of fatty acids having 8 to 30 C atoms,

Mixtures of surface-active hydroxysulfonates according to DE-A-37 25 030,

sulfated hydroxyalkylpolyethylene and / or hydroxyalkylene-propylene glycol ethers according to DE-A-37 23 354,

Sulfonates of unsaturated fatty acids having 8 to 24 C atoms and 1 to 6 double bonds according to DE-A-39 26 344,

Esters of tartaric acid and citric acid with alcohols which are adducts of about 2-15 molecules of ethylene oxide and / or propylene oxide with fatty alcohols having 8 to 22 C atoms,

Alkyl and / or alkenyl ether phosphates of the formula (II),

O

R6 (OC H ₂ CH _{2) P} f OP-OR? (II) OX in the R ^{6 is} preferably an aliphatic hydrocarbon radical having 8 to 30 carbon atoms, R ^{7 is} hydrogen, a radical (CH ₂ CH ₂ O) _n R ⁶ or X, n is from 1 to 10 and X is hydrogen , an alkali or alkaline earth metal or NR ⁸ R ⁹ R ¹⁰ R ¹¹ , with R ⁸ to R ¹¹ independently of one another represents a C 1 to C ₄ hydrocarbon radical,

sulfated fatty acid alkylene glycol esters of the formula (III),

Ri 2 CO (AlkO) _n SO ₃ M (III)

in the R ¹² CO- for a linear or branched, aliphatic, saturated and / or unsaturated acyl radical having 6 to 22 C atoms, Alk for CH ₂ CH ₂ , CHCH ₃ CH ₂ and / or CH ₂ CHCH ₃ , n for numbers from 0.5 to 5 and M is a cation, as described in DE-OS 197 36 906.5, Monoglyceride sulfates and monoglyceride ether sulfates of the formula (IV) as described, for example, in EP-B1 0 561 825, EP-B1 0 561 999, DE-A1 42 04 700 or AKBiswas et al, in J. Am. Soc. 37, 171 (1960) and FUAhmed in J.Am.Oil.Chem.Soc. 67, 8 (1990),

in which R ¹³ CO is a linear or branched acyl radical having 6 to 22 carbon atoms, x, y and z are in total O or numbers from 1 to 30, preferably 2 to 10, and X is an alkali or alkaline earth metal. Typical examples of monoglyceride (ether) sulfates suitable for the purposes of the invention are the reaction products of lauric acid monoglyceride, coconut fatty acid monoglyceride, palmitic acid monoglyceride, stearic acid monoglyceride, oleic acid monoglyceride and tallow fatty acid monoglyceride and their ethylene oxide adducts with sulfur trioxide or chlorosulfonic acid in the form of their sodium salts. Preference is given to using monoglyceride sulfates of the formula (VIII) in which R ¹³ CO is a linear acyl radical having 8 to 18 carbon atoms.

Preferred anionic surfactants are ether carboxylic acid salts having from 10 to 18 carbon atoms in the alkyl group and up to 12 glycol ether groups in the molecule, sulfosuccinic acid mono- and dialkyl esters having from 8 to 18 carbon atoms in the alkyl group and sulfosuccinic acid monoalkyl polyoxyethyl esters having from 8 to 18 carbon atoms in the alkyl group and 1 to 6 oxyethyl groups.

Zwitterionic surfactants are those surface-active compounds which carry at least one quaternary ammonium group and at least one -COO ^H or -SO ₃ ^ group in the molecule. Particularly suitable zwitterionic surfactants are the so-called betaines such as the N-alkyl-N, N-dimethylammoniumglycinate, for example Kokosalkyldimethylammoniumglycinat, N-acyl-aminopropyl-N, N-dimethylammoniumglycinate, for example Kokosacylaminopropyl- dimethylammoniumglycinat, and 2-alkyl-3-carboxymethyl 3-hydroxyethylimidazolines having in each case 8 to 18 C atoms in the alkyl or acyl group, and the cocoacylaminoethyl hydroxyethylcarboxymethylglycinat. A preferred zwitterionic surfactant is the fatty acid amide derivative known by the INCI name Cocamidopropyl Betaine.

Amphoteric surfactants are to be understood as meaning those surface-active compounds which, apart from a C ₈ -C ₂₄ -alkyl or -acyl group in the molecule, contain at least one free amino group and at least one -COOH or -SO ₃ H group and are capable of forming internal salts , Examples of suitable ampholytic surfactants are N-alkylglycines, N-alkylpropionic acids, N-alkylaminobutyric acids, N-alkyliminodipropionic acids, N-hydroxyethyl-N-alkylamidopropylglycines, N-alkyltaurines, N-alkylsarcosines, 2-alkylaminopropionic acids and alkylaminoacetic acids each having about 8 to 24 C Atoms in the alkyl group. Particularly preferred ampholytic surfactants are N-cocoalkylaminopropionate, cocoacylaminoethyl aminopropionate and C ₂ - C ₁₈ - sarcosine.

Nonionic surfactants contain as hydrophilic group z. A polyol group, a polyalkylene glycol ether group or a combination of polyol and polyglycol ether groups. Such compounds are, for example

- With a methyl or C ₂ -C ₆ - alkyl radical end-capped addition products of 2 to 50 moles of ethylene oxide and / or 0 to 5 moles of propylene oxide to linear and branched fatty alcohols having 8 to 30 carbon atoms, to fatty acids having 8 to 30 C atoms and onto alkylphenols having 8 to 15 carbon atoms in the alkyl group, such as the type available under the commercial names Dehydol ^® LS, Dehydol ^® LT (Cognis),

- _C12 o _3-fatty acid mono- and diesters of addition products of 1 to 30 mol ethylene oxide onto glycerol,

Addition products of from 5 to 60 mol of ethylene oxide onto castor oil and hydrogenated castor oil, for example castor oil-hydrogenated + 40 EO, as it is commercially available, for example, under the trade name Cremophor CO 455 from SHC,

- polyol, such as the commercially available product ^® Hydagen HSP (Cognis) or Sovermol - types (Cognis),

- alkoxylated triglycerides,

alkoxylated fatty acid alkyl esters of the formula (V)

R14CO- (OCH ₂ CHR15) OR16 _W (V)

in the R ¹⁴ CO for a linear or branched, saturated and / or unsaturated acyl radical having 6 to 22 carbon atoms, R ^{15 is} hydrogen or methyl, R ^{16 is} linear or branched alkyl radicals having 1 to 4 carbon atoms and w for numbers of

1 to 20,

Amine oxides,

Hydroxymix ethers, as described for example in DE-OS 19738866,

Sorbitan fatty acid esters and adducts of ethylene oxide with sorbitan fatty acid esters such as the polysorbates,

Sugar fatty acid esters and addition products of ethylene oxide with sugar fatty acid esters,

Addition products of ethylene oxide onto fatty acid alkanolamides and fatty amines and

- fatty acid N-alkylglucamides.

Preparations having excellent properties are also obtained if they contain fatty acid esters of ethoxylated glycerol as nonionic surfactants.

These connections are identified by the following parameters. The alkyl radical R contains 6 to 22 carbon atoms and may be both linear and branched. Preference is given to primary linear and methyl-branched in the 2-position aliphatic radicals. Such alkyl radicals are, for example, 1-octyl, 1-decyl, 1-lauryl, 1-myristyl, 1-cetyl and 1-stearyl. Particularly preferred are 1-octyl, 1-decyl, 1-lauryl, 1-myristyl. When using so-called "oxo-alcohols" as starting materials, compounds with an odd number of carbon atoms in the alkyl chain predominate.

The compounds used as surfactant with alkyl groups may each be uniform substances. However, it is generally preferred to use native vegetable or animal raw materials in the production of these substances, so that substance mixtures having different alkyl chain lengths depending on the respective raw material are obtained.

Cationic surfactants for the purposes of the invention are selected from quaternary ammonium compounds, esterquats and / or amidoamines.

Preferred quaternary ammonium compounds are ammonium halides, especially chlorides and bromides, such as alkyltrimethylammonium chlorides, dialkyldimethylammonium chlorides and trialkylmethylammonium chlorides, e.g. B. cetyltrimethylammonium chloride, stearyltrimethylammonium chloride, distearyldimethylammonium chloride, lauryldimethylammonium chloride, lauryldimethylbenzylammonium chloride and tricetylmethylammonium chloride, as well as the imidazolium compounds known under the INCI names Quaternium-27 and Quaternium-83. The long alkyl chains of the above-mentioned surfactants preferably have 10 to 18 carbon atoms.

Esterquats are known substances which contain both at least one ester function and at least one quaternary ammonium group as a structural element. Preferred ester quats are quaternized ester salts of fatty acids with triethanolamine, quaternized ester salts of fatty acids with diethanolalkylamines and quaternized ester salts of fatty acids with 1,2-dihydroxypropyldialkylamines. Such products are marketed under the trade names Stepantex® ^{®, ®} and Dehyquart® Armo- care ^®. The products Armocare ^® VGH-70, a N, N-bis (2-Palmitoyloxy- ethyl) dimethyl ammonium chloride, as well as Dehyquart ^® F-75, Dehyquart ^® C-4046, Dehyquart ^® L80 and Dehyquart ^® AU-35 are examples of such esterquats ,

The alkylamidoamines are usually prepared by amidation of natural or synthetic fatty acids and fatty acid cuts with dialkylaminoamines. An inventively particularly suitable compound from this group of substances that available under the name Tegoamid ^® S 18 commercially stearamidopropyldimethylamine is dimethylamine.

The other surfactants are in the Schaumbadkonzentraten in a concentration of not more than 5 wt .-% - based on the total weight - used.

In a further preferred embodiment of the invention, the Schaumbadkonzentrate further contain a water-insoluble oil component. This can be selected from vegetable, mineral or synthetic oils, as well as mixtures of these components.

As natural (vegetable) oils usually triglycerides and mixtures of triglycerides are used. Preferred natural oils in the context of the invention are coconut oil, (sweet) almond oil, walnut oil, peach kernel oil, avocado oil, tea tree oil, soybean oil, sesame oil, sunflower oil, tsubaki oil, evening primrose oil, rice bran oil, palm kernel oil, mango seed oil, meadowfoam seed oil, thistle oil, macadamia nut oil, Grape seed oil, apricot kernel oil, babushu oil, olive oil, wheat germ oil, pumpkin seed oil, mallow oil, hazelnut oil, safflower oil, canola oil, sasanqua oil, jojoba oil and shea butter. Mineral oils include, in particular, mineral oils, paraffin oils, isoparaffin oils and synthetic hydrocarbons. An inventively employable hydrocarbon is for example the commercial product available as a 1, 3-di- (2-ethylhexyl) -cyclohexane (Cetiol ^® S). Polydecenes are preferred according to the invention.

As synthetic oils, silicone compounds are used in amounts of from 0.05 to 3% by weight and in particular in amounts of from 0.1 to 2% by weight. These may be selected from water-soluble, water-insoluble, volatile or nonvolatile silicones.

Particular preference is given to bubble bath concentrates according to the invention which contain at least one silicone selected from:

(i) polyalkyl siloxanes, polyaryl siloxanes, polyalkylaryl siloxanes which are volatile or nonvolatile, straight chain, branched or cyclic, crosslinked or uncrosslinked;

(ii) polysiloxanes containing in their general structure one or more organofunctional groups selected from: a) substituted or unsubstituted aminated groups; b) (per) fluorinated groups; c) thiol groups; d) carboxylate groups; e) hydroxylated groups; f) alkoxylated groups; g) acyloxyalkyl groups; h) amphoteric groups; i) bisulfite groups; j) hydroxyacylamino groups; k) carboxy groups;

I) sulfonic acid groups; and m) sulfate or thiosulfate groups; (iii) linear polysiloxane (A) - polyoxyalkylene (B) - block copolymers of the type (AB) _n with n>3; (iv) grafted silicone polymers with non-silicone organic

Backbone consisting of an organic backbone formed from organic monomers containing no silicone, referred to in US Pat Chain and optionally at least one chain end of at least one Polysiloxanmakromer was grafted;

(v) grafted polysiloxane backbone silicone polymers to which have been grafted non-silicone organic monomers having a polysiloxane backbone onto which at least one organic macromer not containing silicone has been grafted in the chain, and optionally at least at one of its ends ;

(vi) or mixtures thereof.

Particularly preferred hair treatment compositions according to the invention are characterized in that they contain at least one silicone of the formula I

(CH ₃ ) ₃ Si- [O-Si (CH ₃ ) ₂ ] χ-O-Si (CH ₃ ) 3 (I), in which x is a number from 0 to 100, preferably from 0 to 50, more preferably from 0 to 20 and especially 0 to 10, stands.

The hair treatment agents preferred according to the invention comprise a silicone of the above formula I. These silicones are designated according to the INCI nomenclature as DIMETHICONE.

According to the invention particularly preferred are dimethicone, which at 2O ⁰ C a viscosity of> 6,000 cSt, preferably having such> cSt 20,000 and in particular> 40,000 cSt.

Particularly preferred agents according to the invention contain one or more amino-functional silicones. Such silicones may e.g. through the formula

M (R _a Q _b SiO _(4- a- _b ) _{/ 2} ) x (R _c SiO _{(4. C) / 2)} yM

Will be described, wherein in the above formula R is a hydrocarbon or a hydrocarbon radical having from 1 to about 6 carbon atoms, Q is a polar radical of the general formula -R ¹ HZ, wherein R ^{1 is} a divalent connecting group attached to hydrogen and the Z is an organic, amino-functional radical containing at least one amino-functional group, carbon and hydrogen atoms, carbon, hydrogen and oxygen atoms or carbon, hydrogen and nitrogen atoms; "a" assumes values in the range of about 0 to about 2, "b" assumes values in the range of about 1 to about 3, "a" + "b" less than or is equal to 3, and "c" is a number in the range of about 1 to about 3, and x is a number in the range of 1 to about 2,000, preferably from about 3 to about 50, and most preferably from about 3 to about 25 and y is a number in the range of from about 20 to about 10,000, preferably from about 125 to about 10,000, and most preferably from about 150 to about 1,000, and M is a suitable silicone end group as known in the art, preferably trimethylsiloxy. Non-limiting examples of the groups represented by R include alkyl groups such as methyl, ethyl, propyl, isopropyl, isopropyl, butyl, isobutyl, amyl, isoamyl, hexyl, isohexyl and the like; Alkenyl radicals such as vinyl, halovinyl, alkylvinyl, allyl, haloallyl, alkylallyl; Cycloalkyl radicals such as cyclobutyl, cyclopentyl, cyclohexyl and the like; Phenyl radicals, benzyl radicals, halohydrocarbon radicals such as 3-chloropropyl, 4-bromobutyl, 3,3,3-trifluoropropyl, chlorocyclohexyl, bromophenyl, chlorophenyl and the like, and sulfur containing radicals such as mercaptoethyl, mercaptopropyl, mercaptohexyl, mercaptophenyl and the like; preferably R is an alkyl radical containing from 1 to about 6 carbon atoms, and most preferably R is methyl. Examples of R ¹ include methylene, ethylene, propylene, hexamethylene, decamethylene, -CH ₂ CH (CH ₃ ) CH ₂ -, phenylene, naphthylene, -CH ₂ CH ₂ SCH ₂ CH ₂ -, -CH ₂ CH ₂ OCH ₂ - , -OCH ₂ CH ₂ -, -OCH ₂ CH ₂ CH ₂ -, -CH ₂ CH (CH ₃ ) C (O) OCH ₂ -, - (CH ₂ J ₃ CC (O) OCH ₂ CH ₂ -, - C ₆ H ₄ C ₆ H ₄ -, -C ₆ H ₄ CH ₂ C ₆ H ₄ -; and - (CH _{3 S} ) ₃ C (O) SCH ₂ CH ₂ -.

Z is an organic, amino-functional radical containing at least one functional amino group. A possible formula for Z is NH (CH ₂ ) _Z NH ₂ , wherein z is 1 or more. Another possible formula for Z is -NH (CH ₂ ) ₂ (CH ₂ ) _ZZ NH, wherein both z and zz are independently 1 or more, this structure including diamino ring structures, such as piperazinyl. Z is most preferably a -NHCH ₂ CH ₂ NH ₂ radical. Another possible formula for Z is - N (CH ₂ ) _Z (CH ₂ ) _ZZ NX ₂ or -NX ₂ , wherein each X of X _{2 is} independently selected from the group consisting of hydrogen and alkyl groups of 1 to 12 carbon atoms, and zz is 0.

Q is most preferably a polar, amine functional group of the formula - CH ₂ CH ₂ CH ₂ NH ₂ CH ₂ CH ₂ NH ₂ . In the formulas, "a" assumes values in the range of about 0 to about 2, "b" assumes values in the range of about 2 to about 3, "a" + "b" is less than or equal to 3, and "c "is a number in the range of about 1 to about 3. the molar ratio of R _a Q _b SiO _{(4. a. b) / 2} units to the R ₀ SiO _{(4. c) / 2} units is in the range from about 1: 2 to 1:65, preferably from about 1: 5 to about 1: 65, and most preferably from about 1: 15 to about 1: 20. If one or more silicones of the above formula When used, the various variable substituents in the above formula may be different for the various silicone components present in the silicone blend.

Preferred hair treatment compositions according to the invention are characterized in that they contain an amino-functional silicone of the formula (II)

R _'a G ₃ .a-Si (OSiG _{2) n} - (OSiG

(H).

contain, in which means:

G is -H, a phenyl group, -OH, -O-CH ₃ , -CH ₃ , -O-CH ₂ CH ₃ , -CH ₂ CH ₃ , -O-

CH ₂ CH ₂ CH ₃₁ -CH ₂ CH ₂ CH ₃ , -O-CH (CHS) ₂ , -CH (CH ₃ ) ₂ , -O-CH ₂ CH ₂ CH ₂ CH ₃ , - CH ₂ CH ₂ CH ₂ CH ₃ , -O-CH ₂ CH (CH ₃ ) _2> -CH ₂ CH (CH ₃ ) ₂ , -O-CH (CH ₃ ) CH ₂ CH ₃ , - CH (CH ₃ ) CH ₂ CH ₃ , OC (CH _{3) 3,} -C (CHs) _3;

a is a number between O and 3, in particular O;

b is a number between 0 and 1, in particular 1,

m and n are numbers whose sum (m + n) is between 1 and 2,000, preferably between 50 and 150, where n is preferably from 0 to 1999 and especially from 49 to 149 and m is preferably from 1 to 2000, in particular from 1 to 10,

R ^' is a monovalent radical selected from O -QN (R ") - CH ₂ -CH ₂ -N (R") ₂ o -QN (R ") ₂ O -QN ⁺ (R ¹¹ J ₃ A- o - QN ⁺ H (R ") ₂ A- o -QN ⁺ H ₂ (R") A- o -QN (R ") - CH ₂ -CH ₂ -N ⁺ R" H ₂ A-, where each Q is a chemical bond, -CH ₂ -, -CH ₂ -CH ₂ -, -CH ₂ CH ₂ CH ₂ -, -C (CH ₃ J ₂ -, - CH ₂ CH ₂ CH ₂ CH ₂ -, -CH ₂ C ( CHs) ₂ -, -CH (CH ₃ ) CH ₂ CH ₂ -,

R "is identical or different radicals from the group -H, -phenyl, -benzyl, -CH ₂ - CH (CH ₃ ) Ph, the C _1-20 -alkyl radicals, preferably -CH ₃ , -CH ₂ CH ₃ , - CH ₂ CH ₂ CH ₃ , -CH (CH ₃ ) ₂ , -CH ₂ CH ₂ CH ₂ H ₃ , -CH ₂ CH (CHs) ₂ , -CH (CH ₃ ) CH ₂ CH ₃ , -C (CH ₃ ) ₃ , and A represents an anion, which is preferably selected from chloride, bromide, iodide or methosulfate. Particularly preferred hair treatment compositions according to the invention are characterized in that they contain at least one amino-functional silicone of the formula (IIa)

(CH ₃ ) ₃ Si - [O-Si (CH ₃ ) 2] n [OSi (CH ₃ )] _m - OSi (CH ₃ ) 3 (IIa),

I

CH ₂ CH (CH 3) CH ₂ NH (CH ₂ ) ₂ NH ₂

in which m and n are numbers whose sum (m + n) is between 1 and 2000, preferably between 50 and 150, where n preferably values of 0 to 1999 and in particular of 49 to 149 and m preferably values of 1 to 2000 , in particular from 1 to 10 assumes.

These silicones are referred to as trimethylsilylamodimethicones according to the INCI declaration.

Also particularly preferred are hair treatment compositions according to the invention which contain at least one amino-functional silicone of the formula (IIb)

R- [Si (CH _{3) 2} -O] _n1 [Si (R) -O] _m - [Si (CH ₃₎ 2] n -R ₂ (IIb),

I (CH ₂ ) ₃ NH (CH ₂ ) ₂ NH ₂

in which R is -OH, -O-CH ₃ or a -CH ₃ group and m, n1 and n2 are numbers whose sum (m + n1 + n2) is between 1 and 2,000, preferably between 50 and 150 , where the sum (n1 + n2) preferably assumes values from 0 to 1999 and in particular from 49 to 149 and m preferably values from 1 to 2000, in particular from 1 to 10.

These silicones are referred to as amodimethicones according to the INCI declaration.

Regardless of which amino-functional silicones are used, preference is given to hair-treatment compositions according to the invention which contain an amino-functional silicone whose amine number is above 0.25 meq / g, preferably above 0.3 meq / g and in particular above 0.4 meq / g , The amine number stands for the milliequivalents of amine per gram of amino-functional silicone. It can be determined by titration and also expressed in mg KOH / g. Hair treatment agents preferred according to the invention are characterized in that, based on their weight, they contain 0.01 to 10% by weight, preferably 0.1 to 8% by weight, particularly preferably 0.25 to 7.5% by weight and in particular 0, 5 to 5 wt.% Amino-functional silicone (s) included.

The INCI CYCLOMETHICONE designated cyclic dimethicones are inventively used with preference. Here, hair treatment compositions according to the invention are preferred, the at least one silicone of the formula III

rfO-Si (CH 2), l, - (III)

in which x is a number from 0 to 200, preferably from 0 to 10, more preferably from 0 to 7 and in particular 0, 1, 2, 3, 4, 5 or 6 stands.

The silicones described above have a backbone composed of -Si-O-Si units. Of course, these Si-O-Si units may also be interrupted by carbon chains. Appropriate molecules are accessible by chain extension reactions and are preferably used in the form of silicone-in-water emulsions.

The silicone-in-water emulsions which can be used according to the invention can be prepared by known processes, as disclosed, for example, in US Pat. No. 5,998,537 and EP 0 874 017 A1.

In summary, this method of preparation comprises the emulsifying mixture of components, one of which contains at least one polysiloxane, the other of which contains at least one organosilicone material which reacts with the polysiloxane in a chain extension reaction, with at least one metal ion-containing catalyst for the chain extension reaction, at least one surfactant and water present are.

Chain extension reactions with polysiloxanes are known and may include, for example, the hydrosilylation reaction in which an Si-H group having an aliphatically unsaturated group in the presence of a platinum / rhodium catalyst to form polysiloxanes having some Si (C) _P- Si bonds (p = 1-6), the polysiloxanes also being referred to as polysiloxanes-polysilalkylenes copolymers. The chain extension reaction may also include the reaction of an Si-OH group (e.g., a hydroxy-terminated polysiloxane) with an alkoxy group (e.g., alkoxysilanes, silicates, or alkoxysiloxanes) in the presence of a metal-containing catalyst to form polysiloxanes.

The polysiloxanes used in the chain extension reaction include a ss-linear polymer of the following structure:

R-Si (R ₂ HO-Si (R ₂ H _n -O-SiR ₃

In this structure, each R independently represents a hydrocarbon radical having up to 20 carbon atoms, preferably having 1 to 6 carbon atoms, such as an alkyl group (for example, methyl, ethyl, propyl or butyl), an aryl group (for example, phenyl), or group required for the chain extension reaction ("reactive group", for example Si-bonded H atoms, aliphatically unsaturated groups such as vinyl, allyl or hexenyl, hydroxy, alkoxy, such as methoxy, ethoxy or propoxy, alkoxy-alkoxy, acetoxy, amino, etc.), with the proviso that on average one to two reactive groups are present per polymer, n is a positive number> 1. Preferably, a plurality of the reactive groups, more preferably> 90%, and especially> 98% of the reactive groups, on the terminal Si -Atomen bound in siloxane. Preferably, n is numbers which describe polysiloxanes having viscosities between 1 and 1,000,000 mnf / s, more preferably viscosities between 1,000 and 100,000 mm ² / s.

The polysiloxanes may be branched to a low degree (for example, <2 mol% of the siloxane units), but the polymers are substantially linear, more preferably fully linear. In addition, the substituents R may in turn be substituted, for example with N-containing groups (for example amino groups), epoxy groups, S-containing groups, Si-containing groups, O-containing groups, etc. Preferably, at least 80% of the radicals R are alkyl radicals, especially preferably methyl groups.

The organosilicone material that reacts with the polysiloxane in the chain extension reaction may be either a second polysiloxane or a molecule that acts as a chain extender. When the organosilicone material is a polysiloxane, it has the above-mentioned general structure. In these cases, one polysiloxane in the reaction has (at least) one reactive group, and a second polysiloxane has (at least) a second reactive group that reacts with the first. If the organosilicone material comprises a chain extender agent, this may be a material such as a silane, a siloxane (e.g. disiloxane or trisiloxane) or a silazane. For example, a composition comprising a polysiloxane according to the general structure described above having at least one Si-OH group can be chain extended by reacting with an alkoxysilane (for example, a dialkoxysilane or trialkoxysilane) in the presence of tin or titanium-containing catalysts is reacted.

The metal-containing catalysts in the chain extension reaction are usually specific for a particular reaction. Such catalysts are known in the art and include, for example, metals such as platinum, rhodium, tin, titanium, copper, lead, etc. In a preferred chain extension reaction, a polysiloxane having at least one aliphatically unsaturated group, preferably an end group, is reacted with an organosilicone material Presence of a hydrosysylation catalyst which is a siloxane or polysiloxane having at least one (preferably terminal) Si-H group. The polysiloxane has at least one aliphatically unsaturated group and satisfies the general formula given above in which R and n are as defined by preference, wherein on average between 1 and 2 groups R have one aliphatically unsaturated group per polymer. Representative aliphatic unsaturated groups are, for example, vinyl, allyl, hexenyl and cyclohexenyl or a group R ² CH = CHR ³ in which R ^{2 is} a divalent aliphatic silicon-bonded chain and R ^{3 is} a hydrogen atom or an alkyl group. The organosilicone material having at least one Si-H group preferably has the above-mentioned structure, wherein R and n are as defined above and wherein, on average, between 1 and 2 groups R is hydrogen and n is 0 or a positive integer

This material may be a polymer or a low molecular weight material such as a siloxane (for example, a disiloxane or a trisiloxane).

The polysiloxane having at least one aliphatic unsaturated group and the organosilicone material having at least one Si-H group react in the presence of a hydrosilylation catalyst. Such catalysts are known in the art and include, for example, platinum and rhodium-containing materials. The catalysts may take any known form, for example platinum or rhodium applied to support materials (such as silica gel or activated carbon) or other suitable compounds such as platinum chloride, salts of platinum or chloroplatinic acids. Chloroplatinic acid, either as a commercially available hexahydrate or in anhydrous form, is a preferred catalyst because of its good dispersibility in organosilicone systems and low color changes.

In a further preferred chain extension reaction, a polysiloxane having at least one Si-OH group, preferably an end group, is reacted with an organosilicone material having at least one alkoxy group, preferably a siloxane having at least one Si-OR group or an alkoxysilane having at least two alkoxy groups , In this case, the catalyst used is again a metal-containing catalyst.

For the reaction of an Si-OH group with an Si-OR group, there are many catalysts known from the literature, for example organometallic compounds such as organotin salts, titanates or titanium chelates or complexes. Examples include stannous octoate, dibutyltin dilaurate, dibutyltin diacetate, dimethyltin dineodecanoate, dibutyltin dimethoxide, isobutyltin triceroate, dimethyltin dibutyrate, dimethyltin dineodecanoate, triethyltin tartrate, tin oleate, tin naphthenate, tin butyrate, tin acetate, tin benzoate, tin sebacate, Tin succinate, tetrabutyl titanate, tetraisopropyl titanate, tetraphenyltitant, tetraoctadecyl titanate, titanium naphthanate, ethyltriethanolamine titanate, titanium diisopropyl diethyl acetoacetate, titanium diisopropoxy diacetyl acetonate and titanium tetra alkoxides in which the alkoxide is butoxy or propoxy.

In addition, the silicone-in-water emulsions preferably contain at least one surfactant. These have been described in detail above.

Hair treatment compositions which are likewise preferred according to the invention are characterized in that they contain at least one silicone of the formula IV

R _{3 is} -Si- [O-SiR ₂ ] _x - (CH ₂ ) _n - [O-SiR ₂ ] _y -O-SIR ₃ (IV),

in which R is identical or different radicals from the group -H, -phenyl, -benzyl, -CH ₂ -CH (CH ₃ ) Ph, the Ci _-20- alkyl radicals, preferably -CH ₃ , -CH ₂ CH ₃ , -CH ₂ CH ₂ CH ₃ , -CH (CH ₃ ) ₂ , -CH ₂ CH ₂ CH ₂ CH ₃ , -CH ₂ CH (CH ₃ ) ₂ , -CH (CH ₃ ) CH ₂ CH ₃ , -C (CH ₃ ) ₃ , x and y are a number from 0 to 200, preferably from 0 to 10, more preferably from 0 to 7 and in particular 0, 1, 2, 3, 4, 5 or 6, and n is a number from 0 to 10, preferably from 1 to 8 and in particular from 2, 3, 4, 5, 6. With preference the silicones of the cleaning agents according to the invention are insoluble in water. Hair treatment compositions which are preferred according to the invention are therefore characterized in that they can additionally contain a water-soluble silicone.

Particularly preferred silicone compounds according to the invention are water-insoluble dimethicones and dimethiconols

As the oil component may further serve a dialkyl ether.

Dialkyl ethers which can be used according to the invention are, in particular, di-n-alkyl ethers having a total of from 12 to 36 carbon atoms, in particular 12 to 24 carbon atoms, such as, for example, di-n-octyl ether, di-n-decyl ether, di-n-nonyl ether, di-n-alkyl ether. n-undecyl ether, di-n-dodecyl ether, n-hexyl n-octyl ether, n-octyl n-decyl ether, n-decyl n-undecyl ether, n-undecyl n-dodecyl ether and n-hexyl n-undecyl ether, and Di-tert-butyl ether, di-isopentyl ether, di-3-ethyl decyl ether, tert-butyl n-octyl ether, iso-pentyl n-octyl ether and 2-methylpentyl n-octyl ether.

According to the invention particularly preferred is the di-n-octyl ether, which is commercially available under the name Cetiol ^® OE.

In a further preferred embodiment of the invention, the effect of the active compound combination according to the invention can be further optimized by further fatty substances. Other fatty substances are to be understood fatty acids, fatty alcohols and natural and synthetic waxes, which may be present both in solid form and liquid in aqueous dispersion.

The fatty acids used can be linear and / or branched, saturated and / or unsaturated fatty acids having 6 to 30 carbon atoms. Preference is given to fatty acids having 10 to 22 carbon atoms. Among these were, for example, to name the isostearic as the commercial products Emersol ^® 871 and Emersol ^® 875, and isopalmitic acids such as the commercial product Edenor ^® IP 95, and all other products sold under the trade names Edenor ^® (Cognis) fatty acids. Other typical examples of such fatty acids are caproic, caprylic, 2-ethylhexanoic, capric, lauric, isotridecanoic, myristic, palmitic, palmitoleic, stearic, isostearic, oleic, elaidic, petroselic, linoleic, linolenic and erucic acid and their technical mixtures, which are obtained, for example, in the pressure splitting of natural fats and oils, in the oxidation of aldehydes from Roelen's oxo synthesis or the dimerization of unsaturated fatty acids. Particularly preferred are usually the fatty acid cuttings obtainable from coconut oil or palm oil; In particular, the use of stearic acid is usually preferred.

As fatty alcohols it is possible to use saturated, mono- or polyunsaturated, branched or unbranched fatty alcohols with C ₆ -C ₃₀ -, preferably C ₁₀ -C ₂₂ - and very particularly preferably C ₁₂ -C ₂₂ -carbon atoms. Decanols, octanols, dodecadienol, decadienol, oleyl alcohol, eruca alcohol, ricinoleic alcohol, stearyl alcohol, isostearyl alcohol, cetyl alcohol, lauryl alcohol, myristyl alcohol, arachidyl alcohol, caprylic alcohol, capric alcohol, linoleyl alcohol, linolenyl alcohol and behenyl alcohol are, for example, decanol, octanolol, dodecadienol, decadienol , as well as their Guerbet alcohols, this list should have exemplary and non-limiting character. However, the fatty alcohols are derived from preferably natural fatty acids, which can usually be based on recovery from the esters of fatty acids by reduction. Also usable according to the invention are those fatty alcohol cuts which are produced by reducing naturally occurring triglycerides such as beef tallow, palm oil, peanut oil, rapeseed oil, cottonseed oil, soybean oil, sunflower oil and linseed oil or fatty acid esters formed from their transesterification products with corresponding alcohols, and thus represent a mixture of different fatty alcohols. Such substances are, for example, under the names Stenol ^® such as Stenol ^® 1618 or Lanette ^® such as Lanette ^® O or Lorol ^®, for example, Lorol ^® C8, Lorol C14 ^®, Lorol C18 ^{®, ®} Lorol C8-18, HD-Ocenol ^®, Crodacol ^® such as Crodacol ^® CS, Novol ^®, Eutanol ^® G ₁ Guerbitol ^® 16, Guerbitol ^® 18, Guerbitol ^® 20, Isofol ^® 12, Isofol ^® 16, Isofol ^® 24, Isofol ^® 36, Isocarb ^® 12, Isocarb ^® 16 or Isocarb® ^® 24 available for purchase. Of course, the invention also wool wax alcohols, as are commercially available, for example under the names of Corona ^®, White Swan ^®, Coronet ^® or Fluilan ^® can be used.

As natural or synthetic waxes, solid paraffins or isoparaffins, carnauba waxes, beeswaxes, candelilla waxes, ozokerites, ceresin, spermaceti, sunflower wax, fruit waxes such as apple wax or citrus wax, microwaxes of PE or PP can be used according to the invention. Such waxes are available, for example, from Kahl & Co., Trittau. Other fatty substances are, for example

- Ester oils. Ester oils are to be understood as meaning the esters of C ₆ - C ₃₀ fatty acids with C ₂ - C ₃₀ fatty alcohols. The monoesters of the fatty acids with alcohols having 2 to 24 carbon atoms are preferred. Examples of fatty acid components used in the esters are caproic acid, caprylic acid, 2-ethylhexanoic acid, capric acid, lauric acid, isotridecanoic acid, myristic acid, palmitic acid, palmitoleic acid, stearic acid, isostearic acid, oleic acid, elaidic acid, petroselinic acid, linoleic acid, linolenic acid, elaeostearic acid, arachidic acid, gadoleic acid, behenic acid and Erucic acid and its technical mixtures, for example, in the pressure splitting of natural fats and oils, in the oxidation of aldehydes from the Roelen oxo synthesis or the dimerization of unsaturated fatty acids incurred. Examples of fatty alcohol moieties in the ester oils are isopropyl alcohol, caproic alcohol, capryl alcohol, 2-ethylhexyl alcohol, capric alcohol, lauryl alcohol, isotridecyl alcohol, myristyl alcohol, cetyl alcohol, palmoleyl alcohol, stearyl alcohol, isostearyl alcohol, oleyl alcohol, elaidyl alcohol, petroselinyl alcohol, linolyl alcohol, linolenyl alcohol, elaeostearyl alcohol, arachyl alcohol, gadoleyl alcohol, Behenyl alcohol, erucyl alcohol and brassidyl alcohol and their technical mixtures, for example, in the high-pressure hydrogenation of technical methyl esters based on fats and oils or aldehydes from the Roelen oxo synthesis and as a monomer fraction in the dimerization of unsaturated fatty alcohols incurred. According to the invention particularly preferably isopropyl myristate (IPM Rilanit ^®), isononanoic acid C16-18- alkyl ester (Cetiol ^® SN), 2-ethylhexyl palmitate (Cegesoft ^® 24), stearic acid-2- ethylhexyl ester (Cetiol ^® 868), cetyl oleate, glycerol tricaprylate, Kokosfettalkohol- caprate / caprylate (Cetiol ^® LC), n-butyl stearate, oleyl erucate (Cetiol ^® J 600), isopropyl palmitate (IPP Rilanit ^®), oleyl Oleate (Cetiol ^®), hexyl laurate (Cetiol ^® A), di-n-butyl adipate (Cetiol ^® B), myristyl myristate (Cetiol ^® MM), cetearyl isononanoate (Cetiol ^® SN), oleic acid decyl ester (Cetiol ^® V).

Dicarboxylic acid esters such as di-n-butyl adipate, di (2-ethylhexyl) adipate, di- (2-ethylhexyl) succinate and di-isotridecyl acelate, and diol esters such as ethylene glycol dioleate, ethylene glycol diisotridecanoate, propylene glycol di (2 ethylhexanoate), propylene glycol diisostearate, propylene glycol di-pelargonat, butanediol di-isostearate, Neopentylglykoldicaprylat, symmetrical, asymmetric or cyclic esters of carbonic acid with fatty alcohols, for example described in DE-OS 197 56 454, glycerol carbonate or dicaprylyl carbonate ( Cetiol ^® CC) - ethoxylated or non ethoxylated mono, - di- and trifatty acid esters of saturated and / or unsaturated linear and / or branched fatty acids with glycerol such as Monomuls 90-018 ^{®, ®} Monomuls 90-L12 or Cutina ^® MD.

The total amount of oil and fat components in the compositions according to the invention is usually 1-10% by weight, based on the total agent. Amounts of 2-6 wt .-% are inventively preferred.

In a further preferred embodiment of the invention, the Schaumbadkonzentrate further contain one or more representatives from the group of vitamins, the provitamins, the protein hydrolysates, the plant extracts and / or the UV filter.

According to the invention, such vitamins, pro-vitamins and vitamin precursors are preferred, which are usually assigned to the groups A, B, C, E, F and H.

The group of substances called vitamin A includes retinol (vitamin A ₁ ) and 3,4-didehydroretinol (vitamin A ₂ ). The ß-carotene is the provitamin of retinol. As vitamin A component according to the invention, for example, vitamin A acid and its esters, vitamin A aldehyde and vitamin A alcohol and its esters such as the palmitate and the acetate into consideration. The preparations used according to the invention preferably contain the vitamin A component in amounts of 0.05-1% by weight, based on the total preparation.

The vitamin B group or the vitamin B complex includes vitamin Bi (thiamine) vitamin B ₂ (riboflavin)

Vitamin B ₃ . Under this name, the compounds nicotinic acid and nicotinamide (niacinamide) are often performed. Preferred according to the invention is the nicotinic acid amide, which is preferably contained in the agents according to the invention in amounts of from 0.05 to 1% by weight, based on the total agent. Vitamin B ₅ (pantothenic acid, panthenol and pantolactone). Panthenol and / or pantolactone are preferably used in the context of this group. Derivatives of panthenol which can be used according to the invention are, in particular, the esters and ethers of panthenol and also cationically derivatized panthenols. Individual representatives are for example the Panthenoltriacetat, the Panthenolmonoethylether and its monoacetate as well as in the WO 92/13829 disclosed cationic panthenol derivatives. The said compounds of the vitamin B ₅ type are preferably contained in the agents used according to the invention in amounts of 0.05-10% by weight, based on the total agent. Amounts of 0.1-5 wt .-% are particularly preferred. Vitamin B ₆ (pyridoxine and pyridoxamine and pyridoxal).

Vitamin C (ascorbic acid). Vitamin C is used in the compositions according to the invention preferably in amounts of 0.1 to 3 wt .-%, based on the total agent. Use in the form of palmitic acid ester, glucosides or phosphates may be preferred. The use in combination with tocopherols may also be preferred.

Vitamin E (tocopherols, especially α-tocopherol). Tocopherol and its derivatives, which include in particular the esters such as the acetate, the nicotinate, the phosphate and the succinate, are preferably present in the agents used according to the invention in amounts of 0.05-1% by weight, based on the total agent ,

Vitamin F. The term "vitamin F" is usually understood as meaning essential fatty acids, in particular linoleic acid, linolenic acid and arachidonic acid.

Vitamin H. Vitamin H is the compound (3aS, 4S, 6aR) -2-oxohexahydrothienol [3,4-d] imidazole-4-valeric acid, for which, however, the trivial name biotin has meanwhile become established. Biotin is contained in the agents used according to the invention preferably in amounts of from 0.0001 to 1.0% by weight, in particular in amounts of from 0.001 to 0.01% by weight.

Preferably, the Schaumbadkonzentrate invention contain vitamins, provitamins and vitamin precursors from groups A, B, E and H. Of course, several vitamins and vitamin precursors may be included simultaneously.

Pantolactone, pyridoxine and its derivatives, as well as nicotinic acid amide and biotin, but especially panthenol and its physiologically acceptable derivatives are particularly preferred.

The porotein hydrolysates which are suitable according to the invention are protein hydrolysates from animals, for example from collagen, milk or keratin, from the Plant, for example, from wheat, corn, rice, potatoes, soy or almonds, marine life forms, such as fish collagen or algae, or biotechnologically derived protein hydrolysates. The protein hydrolyzates on which the cationic derivatives according to the invention are based can be obtained from the corresponding proteins by chemical, in particular alkaline or acid hydrolysis, by enzymatic hydrolysis and / or a combination of both types of hydrolysis. The hydrolysis of proteins usually results in a protein hydrolyzate having a molecular weight distribution of about 100 daltons up to several thousand daltons. Preference is given to those cationic protein hydrolyzates whose underlying protein content has a molecular weight of 100 to 25,000 daltons, preferably 250 to 5000 daltons. Furthermore, cationic protein hydrolyzates are understood to mean quaternized amino acids and mixtures thereof. The quaternization of the protein hydrolysates or amino acids is often carried out using quaternary ammonium salts such as N, N-dimethyl-N- (n-alkyl) -N- (2-hydroxy-3-chloro-n-propyl) ammonium halides. In addition, the cationic protein hydrolysates may also be further derivatized. As typical examples of the cationic protein hydrolysates and derivatives according to the invention, those mentioned under the INCI names in the "International Cosmetic Ingredient Dictionary and Handbook", (seventh edition 1997, The Cosmetic, Toiletry, and Fragrance Association 1101 17 * Street, NW, Suite 300 Cocodimium Hydroxypropyl Hydrolyzed Collagen, Cocodimopnium Hydroxypropyl Hydrolyzed Casein, Cocodimonium Hydroxypropyl Hydrolyzed Collagen, Cocodimonium Hydroxypropyl Hydrolyzed Hair Keratin, Cocodimonium Hydroxypropyl Hydrolyzed Keratin, Cocodimonium Hydroxypropyl Hydrolyzed Rice Protein, Cocodimonium Hydroxypropyl Hydrolyzed SiCl, Cocodimonium Hydroxypropyl Hydrolyzed Soy Protein, Cocodimonium Hydroxypropyl Hydrolyzed Wheat Protein, Cocodimonium Hydroxypropyl SiCl Amino Acids, Hydroxypropyl Arginine Lauryl / Myristyl Ether HCl, Hydroxypropyltrimonium Gelatin, Hydroxypropyltrimonium Hydrolyzed Case in, Hydroxypropyltrimonium Hydrolyzed Collagen, Hydroxypropyltrimonium Hydrolyzed Conchiolin Protein, Hydroxypropyltrimonium Hydrolyzed Keratin, Hydroxypropyltrimonium Hydrolyzed Rice Bran Protein, Hydroxypropyltrimonium Hydrolyzed SiCl, Hydroxypropyltrimonium Hydrolyzed Soy Protein, Hydroxypropyl Hydrolyzed Vegetable Protein, Hydroxypropyltrimonium Hydrolyzed Wheat Protein, Hydroxypropyltrimonium Hydrolyzed Wheat Protein / Siloxysilicate, Laurdimonium Hydroxypropyl Hydrolyzed Soy Protein, Lauridimonium Hydroxypropyl Hydrolyzed Wheat Protein, Lauridimonium Hydroxypropyl Hydrolyzed Wheat Protein / Siloxysilicate, Lauryldimonium Hydroxypropyl Hydrolyzed Casein, Lauryldimony Hydroxypropyl Hydrolyzed Collagen, Lauryldimonium Hydroxypropyl Hydrolyzed Keratin, Lauryldimonium Hydroxypropyl Hydrolyzed Soy Protein, Lauryldimony Hydroxypropyl Hydrolyzed Casein, Steardimonium Hydroxypropyl Hydrolyzed Casein, Steardimonium Hydroxypropyl Hydrolyzed Collagen, Steardimonium Hydroxypropyl Hydrolyzed Keratin, Steardimonium Hydroxypropyl Hydrolyzed Rice Protein, Steardimonium Hydroxypropyl Hydrolyzed SiIk , Steardimonium Hydroxypropyl Hydrolyzed Soy Protein, Steardimonium Hydroxypropyl Hydrolyzed Vegetable Protein, Steardimonium Hydroxypropyl Hydrolyzed Wheat Protein, Steartrimonium Hydroxyethyl Hydrolyzed Collagen, Quaternium-76 Hydrolyzed Collagen, Quaternium-79 Hydrolyzed Collagen, Quaternium-79 Hydrolyzed Keratin, Quaternium-79 Hydrolyzed Milk Protein, Quaternium -79 Hydrolyzed Sick, Quaternium-79 Hydrolyzed Soy Protein, Quaternium-79 Hydrolyzed Wheat Protein.

Very particular preference is given to the cationic protein hydrolyzates and derivatives of keratin, collagen, elastin, soy, milk, wheat, silk and almond, particular preference being given to hydroxypropyl-hydrolyzed wheat protein, as it is commercially available, for example, under the trade name Gluadin WQ from Cognis is.

The protein hydrolysates and their derivatives are preferably used in amounts of from 0.01 to 10% by weight, based on the total agent. Amounts of from 0.1 to 5% by weight and in particular from 0.1 to 3% by weight are very particularly preferred.

Preferred plant extracts according to the invention are selected from herbal extracts of green tea, oak bark, stinging nettle, witch hazel, hops, henna, camomile, burdock root, horsetail, white dome, lime blossom, almond, aloe vera, spruce needle, horse chestnut, sandalwood, juniper, coconut, mango, apricot, Lime, Wheat, Kiwi, Melon, Orange, Grapefruit, Sage, Rosemary, Birch, Mallow, Meadowfoam, Quendel, Yarrow, Thyme, Melissa, Hominy, Coltsfoot, Vanilla, Marshmallow, Meristem, Ginseng and Ginger root included.

Particularly preferred according to the invention are the extracts of green tea, almond, aloe vera, coconut, mango, apricot, lime, wheat, vanilla, kiwi and melon, and particularly preferably the extracts of aloe vera, vanilla and melon, Usually these extracts are produced by extraction of the whole plant. However, in individual cases it may also be preferred to prepare the extracts exclusively from flowers and / or leaves of the plant.

As extraction agent for the preparation of said plant extracts water, alcohols and mixtures thereof can be used. Among the alcohols are lower alcohols such as ethanol and isopropanol, but especially polyhydric alcohols such as ethylene glycol and propylene glycol, both as sole extractant and in admixture with water, are preferred. Plant extracts based on water / propylene glycol in a ratio of 1:10 to 10: 1 have proven to be particularly suitable.

The plant extracts can be used according to the invention both in pure and in diluted form. If they are used in diluted form, they usually contain about 2 to 80 wt .-% of active substance and as a solvent used in their extraction agent or extractant mixture.

The plant extracts are used in Schaumbadkonzentraten - based on their weight - in an amount of 0.01 to 5 wt .-%, preferably 0.02 to 4 wt .-% and in particular 0.05 to 3 wt .-%.

Furthermore, in a preferred embodiment of the invention, the effect of the agent according to the invention by UV filters (I) can be increased. The UV filters according to the invention are not subject to any general restrictions with regard to their structure and their physical properties. On the contrary, all UV filters which can be used in the cosmetics sector and whose absorption maximum lies in the UVA (315-400 nm), in the UVB (280-315 nm) or in the UVC (<280 nm) range are suitable. UV filters with an absorption maximum in the UVB range, in particular in the range from about 280 to about 300 nm, are particularly preferred.

The UV filters used according to the invention can be selected, for example, from substituted benzophenones, p-aminobenzoic acid esters,

Diphenylacrylsäureestern, cinnamic esters, Salicylsäureestem, benzimidazoles and o-aminobenzoic acid esters.

Examples of the present invention suitable UV filters are 4-aminobenzoic acid, N ₁ N ₁ N-trimethyl-4- (2-oxoborn-3-ylidenemethyl) aniline methyl sulfate, 3,3,5-trimethyl-cyclohexyl salicylate (homosalates), 2-hydroxy-4-methoxybenzophenone (benzophenone-3, UvinulOM 40, Uvasorb®MET, Neo Heliopan®BB, Eusolex®4360), 2-phenylbenzimidazole-5-sulfonic acid and their potassium, sodium and triethanolamine salts (Phenylbenzimidazole sulfonic acid, Parsol®HS, Neo Heliopan® Hydro), 3,3 '- (1,4-phenylenedimethylene) -bis (7,7-dimethyl-2-oxo-bicyclo [2.2.1] hept 1-yl-methanesulfonic acid) and salts thereof, 1- (4-tert-butylphenyl) -3- (4-methoxyphenyl) -propane-1,3-dione (butylmethoxydibenzoylmethane; Parsol®1789, Eusolex®9020) , α- (2-Oxoborn-3-ylidene) -toluene-4-sulfonic acid and its salts, ethoxylated 4-aminobenzoic acid ethyl ester (PEG-25 PABA, Uvinul®P 25), 4-dimethylaminobenzoic acid 2-ethylhexyl ester (Octyl dimethyl Uvasorb® DMO, Escalol® 507, Eusolex® 6007), 2-ethylhexyl salicylate (Octyl salicylate, Escalol® 587, Neo Heliopan®OS, Uvinul® 018), 4-methoxycinnamic acid isopentyl ester (Isoamyl p-methoxycinnamate; Neo Heliopan®E 1000), 4-methoxycinnamic acid-2-ethyl hexyl ester (octyl methoxycinnamate; Parsol® MCX, Escalol® 557, Neo Heliopan® AV), 2-hydroxy-4-methoxybenzophenone-5-sulfonic acid and its sodium salt (benzophenone-4, Uvinul®MS 40, Uvasorb® S 5), 3- (4'- Methylbenzylidene) -D, L-camphor (4-methylbenzylidene camphor; Parsol® 5000, Eusolex® 6300), 3-benzylidene-camphor (3-benzylidene camphor), 4-isopropylbenzyl salicylate, 2, 4,6-trianilino- (p-) carbo-2'-ethylhexyl-1'-oxi) -1, 3,5-triazine, 3-imidazol-4-yl-acrylic acid and its ethyl ester, polymers of N - {(2 and 4) - [2-oxoboronyl] 3-ylidenemethyl] benzyl} -acrylamide, 2,4-dihydroxybenzophenone (Benzophenone-1, Uvasorb® 20 H, Uvinul® 400), 1, 1 '- 2-ethylhexyl diphenylacrylonitrile acid (Octocrylene; Eusolex®OCR, Neo Heliopan ®Type 303, Uvinul® N 539 SG), o-aminobenzoic acid menthyl ester (menthyl anthranilate; Neo Heliopan®MA), 2,2 ', 4,4'-tetrahydroxybenzophenone (Benzophenone-2; Uvinul® D-50), 2 2'-dihydroxy-4,4'-dimethoxybenzophenone (benzophenone-6), 2,2'-dihydroxy-4,4'-dimethoxybenzophenone-5-sodium sulfonate and 2-cyano-3, 3-diphenylacrylic acid 2'-ethylhexyl ester. Preference is given to 4-aminobenzoic acid, N, N, N-trimethyl-4- (2-oxoborn-3-ylidenemethyl) aniline methylsulfate, 3,3,5-trimethylcyclohexyl salicylate, 2-hydroxy-4-methoxybenzophenone, 2 - phenylbenzimidazole-5-sulfonic acid and its potassium, sodium and triethanolamine salts, 3,3 '- (1 _> 4-phenylenedimethylene) -bis (7,7-dimethyl-2-oxo-bicyclo [2.2.1] hept- 1-yl-methanesulfonic acid) and salts thereof, 1- (4-tert-butylphenyl) -3- (4-methoxyphenyl) -propane-1,3-dione, α- (2-oxoborn-3-ylidene) toluene-4-sulfonic acid and its salts, ethoxylated 4-aminobenzoic acid ethyl ester, 4-dimethylaminobenzoic acid 2-ethylhexyl ester, 2-ethylhexyl salicylate, isopentyl 4-methoxycinnamate, 2-ethylhexyl 4-methoxycinnamate, 2-hydroxy 4-methoxybenzophenone-5-sulfonic acid and its sodium salt, 3- (4'-methylbenzylidene) -D, L-carnpher, 3-benzylidene-camphor, 4-isopropylbenzylsalicylate, 2,4,6-trianilino- (p-carbo-) 2'-ethylhexyl-1'-oxi) -1, 3,5-triazine, 3 imidazol-4-yl-acrylic acid and its ethyl ester, polymers of N - {(2 and 4) - [2-oxoborn-3-ylidenemethyl] benzyl} -acrylamide. Very particularly preferred according to the invention are 2-hydroxy-4-methoxybenzophenone, 2-phenylbenzimidazole-5-sulfonic acid and its potassium, sodium and triethanolamine salts, 1- (4-tert-butylphenyl) -3- (4-methoxyphenyl) Propan-1, 3-dione, 4-methoxycinnamic acid 2-ethylhexyl ester and 3- (4'-methylbenzylidene) -D, L-camphor.

Preference is given to those UV filters whose molar extinction coefficient at the absorption maximum is above 15,000, in particular above 20,000.

Furthermore, it has been found that structurally similar UV filters in many cases the water-insoluble compound in the teaching of the invention has the higher effect compared to such water-soluble compounds that differ from it by one or more additional ionic groups. Within the scope of the invention, water-insoluble UV filters are those which dissolve in water at not more than 1% by weight, in particular not more than 0.1% by weight, at 20 ° C. Furthermore, these compounds should be soluble in the usual cosmetic oil components at room temperature to at least 0.1, in particular at least 1 wt .-%). The use of water-insoluble UV filters may therefore be preferred according to the invention.

According to a further embodiment of the invention, preference is given to those UV filters which have a cationic group, in particular a quaternary ammonium group. These UV filters have the general structure U-Q.

The structural part U stands for a UV-absorbing group. This group can in principle be derived from the known UV filters which can be used in the cosmetics sector, in which a group, generally a hydrogen atom, of the UV filter is replaced by a cationic group Q, in particular having a quaternary amino function ,

Compounds from which the structural part U can derive are, for example

• substituted benzophenones,

• p-aminobenzoic acid ester,

• - diphenylacrylic acid ester, • - cinnamic acid ester,

• salicylic acid ester,

• - benzimidazoles and

• - o-aminobenzoic acid ester.

Structural parts U derived from cinnamic acid amide or from N ₁ N- dimethylamino acid amide are preferable in the invention.

The structural parts U can in principle be chosen such that the absorption maximum of the UV filters can be in both the UVA (315-400 nm) and in the UVB (280-315 nm) or in the UVC (<280 nm) range , UV filters with an absorption maximum in the UVB range, in particular in the range from about 280 to about 300 nm, are particularly preferred.

Furthermore, the structural part U, also as a function of structural part Q, is preferably chosen such that the molar extinction coefficient of the UV filter at the absorption maximum is above 15,000, in particular above 20,000.

The structural part Q preferably contains, as a cationic group, a quaternary ammonium group. This quaternary ammonium group can in principle be connected directly to the structural part U, so that the structural part U represents one of the four substituents of the positively charged nitrogen atom. Preferably, however, one of the four substituents on the positively charged nitrogen atom is a group, especially an alkylene group of 2 to 6 carbon atoms, which functions as a compound between the structural portion U and the positively charged nitrogen atom.

Advantageously, the group Q has the general structure - (CH ₂ ) _X -N ⁺ R ¹ R ² R ³ X ^" , where x is an integer from 1 to 4, R ¹ and R ² independently of one another are C ₁ - ₄ - alkyl groups, R ³ is a C i_ ₂₂ alkyl group or a benzyl group and x ~ is a physiologically acceptable anion Within this general structure, x is preferably the number 3, R ¹ and R ² are each a methyl group. and R ^{3 is} either a methyl group or a saturated or unsaturated, linear or branched hydrocarbon chain having 8 to 22, especially 10 to 18, carbon atoms. Physiologically acceptable anions are, for example, inorganic anions such as halides, in particular chloride, bromide and fluoride, sulfate ions and phosphate ions and organic anions such as lactate, citrate, acetate, tartrate, methosulfate and tosylate.

Two preferred UV filters with cationic groups are the commercially available compounds cinnamic acid amidopropyltrimethylammonium chloride (lncroquat® UV-283) and dodecyldimethylaminobenzamidopropyl dimethylammonium tosylate (Escalol® HP 610).

Of course, the teaching of the invention also includes the use of a combination of several UV filters. In the context of this embodiment, the combination of at least one water-insoluble UV filter with at least one UV filter with a cationic group is preferred.

The UV filters (I) are usually present in the foam bath concentrates according to the invention in amounts of 0.01-5% by weight, based on the total agent. Amounts of 0.05-2.0 wt .-% are preferred.

In addition to the components which are absolutely necessary according to the invention and the other preferred components mentioned above, the agents according to the invention may in principle contain all other components known to the person skilled in the art for such cosmetic compositions.

Further active ingredients, auxiliaries and additives are, for example, nonionic polymers such as, for example, vinylpyrrolidone / vinyl acrylate copolymers, polyvinylpyrrolidone and vinylpyrrolidone / vinyl acetate copolymers and polysiloxanes,

Thickeners such as agar-agar, guar gum, alginates, xanthan gum, gum arabic, karaya gum, locust bean gum, linseed gums, dextrans, cellulose derivatives, e.g. For example, methylcellulose, hydroxyalkylcellulose and carboxymethylcellulose, starch fractions and derivatives such as amylose, amylopectin and dextrins, clays such. As bentonite or fully synthetic hydrocolloids such. For example, polyvinyl alcohol,

conditioning compounds such as phospholipids, for example soya lecithin, egg lecithin and cephalins, and silicone oils, Perfume oils, dimethylisosorbide and cyclodextrins,

Solvents and mediators such as ethanol, isopropanol, ethylene glycol, propylene glycol, glycerol and diethylene glycol,

Symmetrical and unsymmetrical, linear and branched dialkyl ethers having a total of from 12 to 36 carbon atoms, in particular 12 to 24 carbon atoms, such as, for example, di-n-octyl ether, di-n-decyl ether, di-n-nonyl ether, di-n undecyl ether and di-n-dodecyl ether, n-hexyl n-octyl ether, n-octyl n-decyl ether, n-decyl n-undecyl ether, n-undecyl n-dodecyl ether and n-hexyl n-undecyl ether, and di tert-butyl ether, di-isopentyl ether, di-3-ethyl decyl ether, tert-butyl n-octyl ether, iso-pentyl n-octyl ether and 2-methyl pentyl n-octyl ether,

Fatty alcohols, in particular linear and / or saturated fatty alcohols having 8 to 30 carbon atoms,

Monoesters of C8 to C30 fatty acids with alcohols having 6 to 24 carbon atoms,

Fiber-structure-improving active substances, in particular mono-, di- and oligosaccharides, such as, for example, glucose, galactose, fructose, fructose and lactose,

• conditioning agents such as paraffin oils, vegetable oils, eg. Sunflower oil, orange oil, almond oil, wheat germ oil and peach kernel oil as well

Phospholipids, for example soya lecithin, egg lecithin and cephalins,

Quaternized amines such as methyl 1-alkylamidoethyl 2-alkylimidazolinium methosulfate,

Defoamers like silicones,

Dyes for staining the agent,

• active ingredients such as allantoin and bisabolol,

• cholesterol,

Bodying agents such as sugar esters, polyol esters or polyol alkyl ethers,

Fats and waxes like spermaceti, beeswax, montan wax and paraffins,

Fatty acid alkanolamides, Complexing agents such as EDTA, NTA, β-alaninediacetic acid and phosphonic acids,

• swelling and penetrating substances such as primary, secondary and tertiary phosphates,

Opacifiers such as latex, styrene / PVP and styrene / acrylamide copolymers

Pearlescing agents such as ethylene glycol mono- and distearate and PEG-3-distearate,

• pigments,

Propellants such as propane-butane mixtures, N ₂ O, dimethyl ether, CO ₂ and air,

• antioxidants.

With regard to further optional components as well as the amounts of these components used, reference is expressly made to the relevant manuals known to the person skilled in the art, eg. For example, the above monograph by KH Schrader referenced.

Examples:

foam bath

Sodium Laureth Sulfate 20% telquel

Laureth-2 4% telc

Laureth-4 8% telc

Propylene glycol 30% telquel

Glycerin 26,26% telquel

PEG-7 Glyceryl Cocoate 5% telquel

Caprylic / Capric triglycerides 1, 5% telquel

Perfume, stain ad 100 ad

The Schaumbadkonzentrat, in a water-soluble liquid film M 8630 of the company

Monosol is suitable as a single serving for a full bath and has an excellent performance profile.

Claims

claims:

1. foam bath concentrate having a total water content of at most 7 wt .-%, containing surfactants, polyols and at least one fatty substance component, characterized in that it is included in a water-soluble liquid film.

2. Schaumbadkonzentrat according to claim 1, characterized in that it contains a surfactant mixture of anionic and nonionic surfactants.

3. Schaumbadkonzentrat according to claim 2, characterized in that it

10 to 30 wt .-% of at least one alkyl ether sulfate surfactant and 5 to 15 wt .-% of at least one nonionic surfactant selected from compounds of

formula

RA- (C ₂ H ₄ O) _x -H, where R is an alkyl, alkenyl or acyl group of 10 to 18 carbon atoms, A is an oxygen atom or an -NH group and x is a number from 2 to 10, or alkylpolyglucosides.

4. Schaumbadkonzentrat according to one of claims 1 to 3, characterized in that it contains 20 to 70 wt .-% of a polyol selected from glycerol, propylene glycol or polyethylene glycol and mixtures thereof.

5. Schaumbadkonzentrat according to one of claims 1 to 4, characterized in that it contains as Fettstoffkomponente 1 to 8 wt .-% of at least one Glycerinpolyglycolether monofatty acid ester or a Fettsäuremonooder diglyceride polyglycolethers.

6. Schaumbadkonzentrat according to one of claims 1 to 5, characterized in that it further comprises a cationic polymer.

7. Schaumbadkonzentrat according to one of claims 1 to 6, characterized in that it contains at least one further water-insoluble oil component.

8. Schaumbadkonzentrat according to claim 7, characterized in that it contains silicones such as dimethicones and / or dimethiconols, polydecenes and / or vegetable oils.

9. Schaumbadkonzentrat according to one of claims 1 to 8, characterized in that it further contains one or more representatives from the group of vitamins, provitamins, protein hydrolysates, plant extracts and / or UV filters.

10. Schaumbadkonzentrat according to one of claims 1 to 9, characterized in that it is included in a liquid film of polyvinyl alcohol.

11. Schaumbadkonzentrat according to claim 10, characterized in that the liquid film has a thickness of 70 to 80 microns and a dimension of 130 to 150 x 80 to 90 mm.